Evidence map›Paper›PMID 18984467›Full record

ReviewClinics in liver disease2008

Stellate cell contraction: role, regulation, and potential therapeutic target.

Russell K Soon, Hal F Yee

Open access · greenAbstract readReview
In one paragraph

Review in Clinics in liver disease, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Liver Fibrosis: Interactions Between Cells and Microenvironments.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Review
  3. Review
  4. Article
  5. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.International journal of molecular sciences · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Discovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cells.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2016
    Review
  16. Article
  17. Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis.Oxidative medicine and cellular longevity · 2015
    Review
  18. Establishment and characterization of an immortalized rat hepatic stellate cell line.International journal of clinical and experimental pathology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Russell K SoonDepartment of Medicine and Liver Center, University of California, San Francisco, CA 94110, USA.
Hal F Yee
University of California, San Francisco · US

Funding

Regulation of Hepatic Stellate Cell Responses to InjuryR01DK061532 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YEE, HAL F · 2003 to 2007
$1.4M
NIDDK NIH HHS R01 DK061532NIDDK NIH HHS R01 DK61532
6 · The paper itself

Abstract

The contraction of hepatic stellate cells has been proposed to mediate fibrosis by regulating sinusoidal blood flow and extracellular matrix remodeling. Abundant data from diverse, yet complementary, experimental methods support a robust model for the regulation of contractile force generation by stellate cells. In this model, soluble factors associated with liver injury, including endothelin 1 and nitric oxide, are transduced primarily through Rho signaling pathways that promote the myosin II-powered generation of contractile force by stellate cells. The enhanced knowledge of the role and differential regulation of stellate cell contraction may facilitate the discovery of new and targeted strategies for the prevention and treatment of hepatic fibrosis.

Indexed as

AnimalsContractile ProteinsEndothelin-1Extracellular MatrixHepatic Stellate CellsHumansIntracellular Signaling Peptides and ProteinsLiver CirrhosisMyosin Type IINitric OxidePortal Systemrho-Associated KinasesSignal TransductionContractile ProteinsEndothelin-1Intracellular Signaling Peptides and ProteinsMyosin Type IINitric Oxiderho-Associated Kinases

Identifiers

PMID18984467
PMCPMC2600510
OpenAlexW2163713066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.